Key Takeaways:
Aspire Biopharma Holdings agreed to buy Dura Driver Control Systems for $30 million in cash, a deal that transforms the $1 million market-cap drug developer into a $200 million-plus automotive supplier.
"Our acquisition of DCS provides Aspire with immediate, high-volume revenue-generating operations and growth capabilities," said Kraig Higginson, interim CEO and chairperson of Aspire's board.
DCS, a tier-one automotive supplier with more than 100 years of history, generated over $200 million in revenue and more than $22 million in adjusted EBITDA for the fiscal year ended Dec. 31, 2025. Aspire, by contrast, reported just $30,000 in revenue over the past 12 months and its stock has fallen 99% in the past year to about $6 per share.
The $30 million purchase price — roughly 1.4 times DCS's trailing EBITDA — gives Aspire immediate scale across 11 manufacturing facilities in North America, Europe and Asia, plus a portfolio of more than 310 patents. The company said it does not expect to raise new equity to fund the deal, which is expected to close in the third quarter.
DCS designs and manufactures mechatronic actuators, human-machine interfaces and cable control systems for more than 50 customers, including major global automakers. Its top 10 original equipment manufacturer clients have an average relationship of 28 years, and its products appear on more than 250 vehicle models across 150 platforms. The company holds more than 310 patents and employs 55 design and product engineers across two global technical centers.
The acquisition marks a sharp strategic pivot for Aspire, which had been developing a sublingual drug delivery technology and a caffeine product line under its Buzz Bomb Caffeine Company subsidiary. The company completed a $21 million private placement of convertible preferred stock earlier this year and authorized a $5 million stock buyback program to address Nasdaq compliance requirements.
RBW Capital Partners LLC served as exclusive financial advisor to Aspire. Dawson James Securities Inc. will handle any related securities or brokerage services. DCS Chief Executive Hans Vorstenbosch will remain as CEO of the subsidiary, with oversight from Gregory J. Corona, chairman of Lakewood & Company, which brings more than 200 years of combined automotive industry experience to the combined entity.
The transaction is subject to customary closing conditions and regulatory approvals. Aspire said it does not anticipate needing new equity financing to complete the purchase.
This article is for informational purposes only and does not constitute investment advice.
